Cochrane · systematic review · CD010237
Tong‐xin‐luo capsule for patients with coronary heart disease after percutaneous coronary intervention
Mao, C, Fu, XH, Yuan, JQ, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library
HeartAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
8
current version
GRADE rated
7
No studies
1
Included studies
NR
No studies 1 · 12.5%Ungraded 0 · 0%Very low 3 · 37.5%Low 4 · 50%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: participants with CHD after PCI
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Occurrence of angiographic restenosis [ | RR 0.16 [0.07, 0.34] | 6 studies · 595 participants | Low |
Adverse event | no estimate extracted | NR | No studies |
Occurence of myocardial infarction [ | RR 0.32 [0.16, 0.66] | 13 studies · 1306 participants | Low |
Occurrence of angina [ | RR 0.24 [0.17, 0.34] | 11 studies · 1210 participants | Very low |
Occurence of heart failure [ | RR 0.26 [0.11, 0.62] | 4 studies · 529 participants | Low |
All‐cause mortality [ | RR 0.38 [0.06, 2.56] | 4 studies · 419 participants | Very low |
Mortality due to any cardiovascular event [ | RR 0.31 [0.08, 1.12] | 5 studies · 552 participants | Very low |
Use of revascularisation [ | RR 0.26 [0.15, 0.45] | 8 studies · 806 participants | Low |